320 mill possible patients
Lower dosage required so fewer side effects
Proof of concept/study trial completed and highly successful
No trials needed ie phase 1-3, already been fully tested, already an approved drug
Fast acting ie 6x faster than viagra and unlike viagra doesnt mix with food/drink and therefore not work
Current market 6 bill
Mayne health manufacturing, test batches already completed
Trial results all published in journals
Revenue will start in 2024
Consistent news flow approx 1 major ann per month for next year
US distribution to begin 2025
Looking at additional products in the medium term
320 mill possible patients Lower dosage required so fewer side...
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.93 |
Change
-0.130(6.31%) |
Mkt cap ! $163.6M | |||
| Open | High | Low | Value | Volume |
| $2.05 | $2.05 | $1.89 | $1.706M | 872.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 14042 | $1.93 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.94 | 1182 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| LTP (ASX) Chart |